Coya Therapeutics (COYA) Stock Forecast: StockMap's 2-Week Call
COYA stock forecast: StockMap's model makes no two-week call on Coya Therapeutics after the Nov 19 close: its evidence is split, 6 reasons for and 9 against. Right in 2 of 4 two-week windows on COYA since Aug 21; by chance, a call on the same dates was right 69% of the time.
Coya Therapeutics last closed at $2.98, -3.56% on the session.
Against the IVW growth benchmark the position is -1.23% over the forecast window.
Coya Therapeutics' market cap is $69.90M as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 1 (too close to call).
Where COYA sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 6 bullish and 9 bearish.
Agreement across those insights is 40%.
24 daily calls for COYA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Coya Therapeutics in the 14th percentile on return on equity, where 100 is best.
Coya Therapeutics is classified under Health Care / Biotechnology.
StockMap tracks Coya Therapeutics as the 293rd largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite Coya Therapeutics ranks 55th of 394 in the group, against a group median of -0.27.